Literature DB >> 20031865

Comparing methods of measuring treatment intensification in hypertension care.

Adam J Rose1, Dan R Berlowitz, Meredith Manze, Michelle B Orner, Nancy R Kressin.   

Abstract

BACKGROUND: Greater treatment intensification (TI) improves hypertension control. However, we do not know the ideal way to measure TI for research and quality improvement efforts. We compared the ability of different TI measures to predict blood pressure (BP) control. METHODS AND
RESULTS: We enrolled 819 hypertensive outpatients from an urban academic hospital. Each patient was assigned 3 scores to characterize TI. The any/none score divides patients into those who had any therapy increases during the study versus none. The norm-based method models the chance of a medication increase at each visit, then scores each patient based on whether they received more or fewer medication increases than predicted. The standard-based method is similar to the norm-based method but expects a medication increase whenever the blood pressure is uncontrolled. We compared the ability of these scores to predict the final systolic blood pressure (SBP). The any/none score showed a paradoxical result: any therapy increase was associated with SBP 4.6 mm Hg higher than no increase (P<0.001). The norm-based method score did not predict SBP in a linear fashion (P=0.18); further investigation revealed a U-shaped relationship between the norm-based method score and SBP. However, the standard-based method score was a strong linear predictor of SBP (2.1 mm Hg lower for each additional therapy increase per 10 visits, P<0.001). Similarly, the standard-based method predicted dichotomized blood pressure control, as measured by SBP <140 mm Hg (odds ratio, 1.30; P<0.001).
CONCLUSIONS: Our results suggest that standard-based method is the preferred measure of treatment intensity for hypertension care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031865      PMCID: PMC2801893          DOI: 10.1161/CIRCOUTCOMES.108.838649

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  24 in total

1.  Commentary--improving diabetes care by combating clinical inertia.

Authors:  Patrick J O'Connor
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

2.  Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.

Authors:  Richard Grant; Alyce S Adams; Connie Mah Trinacty; Fang Zhang; Ken Kleinman; Stephen B Soumerai; James B Meigs; Dennis Ross-Degnan
Journal:  Diabetes Care       Date:  2007-01-26       Impact factor: 19.112

3.  Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.

Authors:  Eni C Okonofua; Kit N Simpson; Ammar Jesri; Shakaib U Rehman; Valerie L Durkalski; Brent M Egan
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

4.  Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

Authors:  P Michael Ho; David J Magid; Susan M Shetterly; Kari L Olson; Pamela N Peterson; Frederick A Masoudi; John S Rumsfeld
Journal:  Arch Intern Med       Date:  2008-02-11

5.  Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.

Authors:  Monika M Safford; Richard Shewchuk; Haiyan Qu; Jessica H Williams; Carlos A Estrada; Fernando Ovalle; Jeroan J Allison
Journal:  J Gen Intern Med       Date:  2007-10-24       Impact factor: 5.128

6.  Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension.

Authors:  Shari Danielle Bolen; T Alafia Samuels; Hsin-Chieh Yeh; Spyridon S Marinopoulos; Maura McGuire; Marcela Abuid; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2008-01-25       Impact factor: 5.128

7.  Effect of unrelated comorbid conditions on hypertension management.

Authors:  Barbara J Turner; Christopher S Hollenbeak; Mark Weiner; Thomas Ten Have; Simon S K Tang
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

8.  The accuracy of clinician perceptions of "usual" blood pressure control.

Authors:  Adam J Rose; Stephanie L Shimada; James A Rothendler; Joel I Reisman; Peter A Glassman; Dan R Berlowitz; Nancy R Kressin
Journal:  J Gen Intern Med       Date:  2007-11-28       Impact factor: 5.128

9.  Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

Authors:  Michael L Parchman; Jacqueline A Pugh; Raquel L Romero; Krista W Bowers
Journal:  Ann Fam Med       Date:  2007 May-Jun       Impact factor: 5.166

10.  Understanding uncontrolled hypertension: is it the patient or the provider?

Authors:  Adam J Rose; Dan R Berlowitz; Michelle B Orner; Nancy R Kressin
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

View more
  15 in total

1.  Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients.

Authors:  Thomas M Maddox; Colleen Ross; Heather M Tavel; Ella E Lyons; Maggie Tillquist; P Michael Ho; John S Rumsfeld; Karen L Margolis; Patrick J O'Connor; Joe V Selby; David J Magid
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-20

2.  The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Julie A Schmittdiel; P Michael Ho
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

3.  Understanding racial disparities in treatment intensification for hypertension management.

Authors:  Meredith Manze; Adam J Rose; Michelle B Orner; Dan R Berlowitz; Nancy R Kressin
Journal:  J Gen Intern Med       Date:  2010-04-13       Impact factor: 5.128

4.  Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

Authors:  Phillip D Levy; Robina Josiah Willock; Michael Burla; Aaron Brody; James Mahn; Alexander Marinica; Samar A Nasser; John M Flack
Journal:  J Am Soc Hypertens       Date:  2016-10-28

5.  Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.

Authors:  Christianne L Roumie; Alan J Zillich; Dawn M Bravata; Heather A Jaynes; Laura J Myers; Joseph Yoder; Eric M Cheng
Journal:  Stroke       Date:  2014-12-30       Impact factor: 7.914

Review 6.  Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions.

Authors:  Kenneth E Freedland; David C Mohr; Karina W Davidson; Joseph E Schwartz
Journal:  Psychosom Med       Date:  2011-05-02       Impact factor: 4.312

7.  Gender differences in cardiovascular risk factors in incident diabetes.

Authors:  Emily B Schroeder; Elizabeth A Bayliss; Stacie L Daugherty; John F Steiner
Journal:  Womens Health Issues       Date:  2014 Jan-Feb

8.  An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control.

Authors:  Irene V Blair; John F Steiner; Rebecca Hanratty; David W Price; Diane L Fairclough; Stacie L Daugherty; Michael Bronsert; David J Magid; Edward P Havranek
Journal:  J Gen Intern Med       Date:  2014-02-19       Impact factor: 5.128

Review 9.  Therapeutic Inertia and Treatment Intensification.

Authors:  Robina Josiah Willock; Joseph B Miller; Michelle Mohyi; Ahmed Abuzaanona; Meri Muminovic; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-01-29       Impact factor: 5.369

10.  Intensifying therapy for hypertension despite suboptimal adherence.

Authors:  Adam J Rose; Dan R Berlowitz; Meredith Manze; Michelle B Orner; Nancy R Kressin
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.